4//SEC Filing
Shearman Mark S 4
Accession 0001415889-22-006631
CIK 0001650664other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:15 PM ET
Size
4.9 KB
Accession
0001415889-22-006631
Insider Transaction Report
Form 4
Shearman Mark S
EVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-06-15$10.06/sh−5,145$51,745→ 68,349 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 19, 2021 and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units and in performance stock units on June 14, 2022. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001643799
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:15 PM ET
- Size
- 4.9 KB